Upper lip metastasis of sarcomatoid carcinoma of the lung – an unusual site of disease: a case report by Tri Le et al.
CASE REPORT Open Access
Upper lip metastasis of sarcomatoid
carcinoma of the lung – an unusual
site of disease: a case report
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Abstract
Background: Lip metastases are rare clinical events that are frequently mistaken for other diagnoses. For sarcomatoid
lung carcinoma, a rare histologic variant of non-small cell lung cancer, the incidence and pattern of cutaneous spread
is poorly understood.
Case presentation: We present a case of a 79-year-old African American man with a rapidly progressive upper lip
cutaneous lesion that provided the first evidence of distant metastatic spread of sarcomatoid lung carcinoma.
Conclusions: This is the first reported case of lip metastasis in sarcomatoid lung carcinoma. It highlights the
importance of maintaining a high level of suspicion for metastatic disease in the presence of new cutaneous findings
as they may be the first evidence of advanced disease.
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Background
Sarcomatoid lung carcinoma is an aggressive and rare
histologic variant of non-small cell lung cancer
(NSCLC; 0.3 to 1.3% of all lung malignancies) that is
morphologically defined by components of sarcoma
or sarcoma-like differentiation (for example, spindles
and/or giant cells) [1]. Prompt recognition of metastatic
progression is critical to management, as staging deter-
mines treatment and prognosis. The skin provides a non-
invasive opportunity to identify metastatic disease, but the
pattern and incidence of cutaneous spread in this disease
remains unknown. Here, we present a case of rapidly
progressive upper lip cutaneous metastasis from a case of
sarcomatoid lung carcinoma. To the best of our know-
ledge, it is the first documented case of lip metastasis in
this disease, establishing the lip as a potential site of
spread.
Case presentation
A 79-year-old African American man with a history
notable for heavy tobacco use, traumatic brain injury
following a motor vehicle accident, hypothyroidism, and
chronic lymphocytic leukemia last requiring therapy 4
years previously presented with 1 month of persistent
cough. On a chest X-ray, a large mass in the mid-lung
zone of his left lung was noted. Chest computed tomog-
raphy (CT) demonstrated a mass in the upper lobe of
his left lung measuring 7.7×8.7 cm and a 1.1 cm left
hilar lymph node (Fig. 1a). A CT-guided percutaneous
biopsy of the lung mass revealed malignant spindled and
focally epithelioid neoplasm with extensive necrosis with
poor differentiation favoring sarcomatoid carcinoma
(Fig. 1b). Immunohistochemistry demonstrated positive
staining for epithelial markers CAM5.2 (Fig. 1c), cyto-
keratin (CK) 5/6, CK903, and CK7, and negative staining
for thyroid transcription factor 1 (TTF-1), p63, desmin,
S100, and paired-box gene 8 (PAX8).
At this time, he was also noted to have an ulcerated
area on his upper lip on which topical anesthetic agents
were placed. Seven days later, a follow-up examination
revealed painful and substantial upper lip swelling. An ab-
scess was suspected, systemic antibiotics were prescribed,
and he was referred urgently to our Otolaryngology
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service. He was found to have a 2.7 cm upper lip mass with
normal overlying skin. A CT of his neck revealed a 2.1 cm
anteroposterior (AP) × 3.6 cm transverse × 3.8 cm cranio-
caudal (CC) right upper lip mass with surrounding inflam-
matory change (Fig. 2a). An incisional biopsy demonstrated
metastatic sarcomatoid carcinoma, with morphologic and
immunohistochemical characteristics similar to the primary
lung lesion (Fig. 2b, c).
Subsequent imaging demonstrated two intracranial
metastases. He received palliative radiation 3000 cGy in
10 fractions to his upper lip and 3000 cGy in 10 frac-
tions to his brain. He continued to decline functionally;
he was admitted to our in-patient hospice unit, and died
39 days after initial diagnosis of the primary sarcomatoid
lung cancer.
Discussion
Sarcomatoid lung carcinoma is an aggressive and rare
histologic variant of NSCLC (0.3 to 1.3% of all lung malig-
nancies) that is morphologically defined by components of
sarcoma or sarcoma-like differentiation (for example,
spindles and/or giant cells) [1]. There are five primary
subgroups recognized under the 2004 and the 2015 World
Health Organization Classification of Tumors of the Lung:
pleomorphic carcinoma, spindle cell carcinoma, giant cell
carcinoma, carcinosarcoma, and pulmonary blastoma
[1–4]. Relative to other NSCLC histologies, sarcomatoid
carcinoma has poorer stage-by-stage prognosis [3] and
earlier recurrence after resection. The average age at
diagnosis is 60 to 65 years [1, 3, 5–15]. Several studies
suggested an increased male prevalence [1, 2, 4, 5, 8, 11],
while others, including the largest epidemiologic study to
date using the Surveillance, Epidemiology, and End
Results database, suggested a nearly 1-to-1 gender ratio
[3, 12]. Sarcomatoid carcinoma is associated with heavy
tobacco smoking history [1, 9, 15]. Clinical symptoms are
nonspecific (for example, cough, hemoptysis, dyspnea,
thoracic pain, weight loss, fatigue, and fever due to recur-
rent pneumonia) and are often related to pulmonary
tumor localization [1, 9, 11, 14].
In the limited experience reported for this aggres-
sive disease, treatment varies significantly with stage.
Local disease appears to have a good outcome with
surgical resection alone [15]. In metastatic disease,
systemic chemotherapy continues to be to be the
mainstay of treatment. Unfortunately, the response to
conventional NSCLC therapy is poorer than that of
more common histologic variants [16]. Given the
distinction in prognosis and treatment between local
disease and distant spread, it is critical to identify
metastatic disease early. Cutaneous involvement involving
the face is a readily available, noninvasive opportunity for
physicians to identify metastatic disease in the absence of
sites of spread.
Fig. 1 Primary sarcomatoid non-small cell lung cancer. a A 7.7×8.7 cm mass in the upper lobe of the left lung and the lingula causing extrinsic
compression of the left pulmonary artery and its branches with extension into the left superior pulmonary vein, mediastinum, and probably the
pericardium. b Core fragments of lung mass demonstrating spindle cell processes, large areas of necrosis, and intermediate-sized nuclei (100×).
c Immunohistochemical staining with cells positive for CAM5.2 (100×)
Fig. 2 Sarcomatoid non-small cell lung cancer metastasis to upper lip. a A 2.1 cm anteroposterior × 3.6 cm transverse × 3.8 cm craniocaudal
rim-enhancing mass involving the right upper lip with mild surrounding inflammatory changes. b Scant benign superficial epithelium with an
overriding subepithelial spindle and epithelioid cell neoplastic population with intermediate-sized nuclei with some degeneration and moderate
amounts of pink cytoplasm, scattered multinucleated giant cells, and small intratumoral foci of necrosis (100×). c Immunohistochemical staining
with scattered MNF116-positive cells (100×)
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Malignancy involving the lip is a rare clinical event
and largely represented by primary squamous cell (49%)
and basal cell (40%) carcinomas. Other etiologies include
salivary gland origin (9%) and metastatic cancer to the
lip (2%) [17]. Among the few reported cases of lip
metastases in the literature, lung, gastric adenocarcin-
oma, breast, lymphoma, and renal cell carcinoma are
described [18]. Clinical manifestation is often a sub-
mucosal mass with intact overlying skin, occasionally
with ulceration, as was observed in this case [19]. To
the best of our knowledge, this is the first reported
case of sarcomatoid carcinoma of the lung metastasizing
to the lip. High suspicion for metastatic disease should be
maintained when new skin findings are observed in pa-
tients with a known cancer diagnosis, with low threshold
for early histologic confirmation by biopsy.
Conclusions
This case establishes the lip as a potential site of metastatic
spread for sarcomatoid lung carcinoma. Lip and other
cutaneous metastases provide an easily identifiable oppor-
tunity to diagnose distant disease in patients with cancer
diagnoses.
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